Aromatase inhibitors (AIs) are a first-line therapy for postmenopausal women diagnosed with estrogen receptor-positive breast cancer. Because of the estrogen…
Osteoporosis is associated with increased morbidity, mortality, and healthcare costs—billions of dollars annually. Although many types of pharmacotherapy are available…